Identity
- Method
- LC-MS
- Status
- Pass
Current documented batch
Match this report to the batch code on your vial.
Certificate of Analysis
Retatrutide 30 mg
- Batch RT3026233GX
- Tested August 28, 2026
- Freedom Diagnostics Testing
Testing passed
Review the results and original report below. Match the batch number, cap and crimp with your vial.
Measured values
- Purity
- 99.86% Pass Purity measured by the laboratory.
- Measured content
- 32.78 mg ReportedContent measured during testing.
- Labeled content
- 30 mg Amount stated on the vial submitted for testing.
Testing overview
- IdentityPass
- PurityPass
- Measured contentMeasured
- SterilityPass
- Fentanyl screeningPass
- Heavy metalsPass
- EndotoxinsPass
Independent laboratory data
| Test | Laboratory evidence | Status |
|---|---|---|
| Identity |
| Pass |
| Purity |
| Pass |
| Measured content |
| Reported |
| Heavy Metals |
| Pass |
| Sterility |
| Pass |
| Endotoxins |
| Pass |
| Fentanyl Screen |
| Pass |
Purity
- Method
- HPLC-UV
- Result
- 99.86%
- Status
- Pass
Measured content
- Result
- 32.78 mg
- Status
- Reported
Heavy Metals
- Result
- ICP-MS - Arsenic, Cadmium, Lead, and Mercury below reporting/specification limits
- Status
- Pass
Sterility
- Result
- Microbial Analysis (PCR) - No Detectable Microbial DNA
- Status
- Pass
Endotoxins
- Result
- Limulus Amebocyte Lysate assay in accordance with USP <85> ≤0.05 EU/mL
- Status
- Pass
Fentanyl Screen
- Method
- Immunoassay
- Specification
- Immunoassay, 50 ng/mL cutoff
- Result
- Not detected
- Status
- Pass
Original document
Certificate pages
Expand to view pages
Original document
Certificate pages
Source documentation
Laboratory Report
Original analysis from the independent laboratory.
Report details
- Laboratory
- Freedom Diagnostics Testing
- COA reference
- 2608270076
- Analysis date
- August 28, 2026
Freedom Diagnostics TestingIndependent Testing Laboratorycoas.freedomdiagnosticstesting.com
